Biosino Bio-Technology and Science (HKSE:08247) Change In Receivables : HK$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Change In Receivables?

Biosino Bio-Technology and Science's change in receivables for the quarter that ended in Dec. 2023 was HK$0.0 Mil. It means Biosino Bio-Technology and Science's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Biosino Bio-Technology and Science's change in receivables for the fiscal year that ended in Dec. 2023 was HK$38.4 Mil. It means Biosino Bio-Technology and Science's Accounts Receivable declined by HK$38.4 Mil from Dec. 2022 to Dec. 2023 .

Biosino Bio-Technology and Science's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$195.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Biosino Bio-Technology and Science's Days Sales Outstanding for the three months ended in Dec. 2023 was 207.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Biosino Bio-Technology and Science's liquidation value for the three months ended in Dec. 2023 was HK$-113.9 Mil.

Biosino Bio-Technology and Science Change In Receivables Historical Data

The historical data trend for Biosino Bio-Technology and Science's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Change In Receivables Chart

Biosino Bio-Technology and Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-98.65

19.76

-3.21

-9.53

38.44

Biosino Bio-Technology and Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Biosino Bio-Technology and Science Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Biosino Bio-Technology and Science (HKSE:08247) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Biosino Bio-Technology and Science's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	195.565	/	85.871	*	91
=	207.82

2. In Ben Graham's calculation of liquidation value, Biosino Bio-Technology and Science's accounts receivable are only considered to be worth 75% of book value:

Biosino Bio-Technology and Science's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	69.357	-	362.967	+	0.75 * 195.565	+	0.5 * 66.075
=	-113.9

Biosino Bio-Technology and Science Change In Receivables Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200

Website

http://www.zhongsheng.com.cn

Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.

Executives

Beijing Enterprises Group Company Limited	2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited	2101 Beneficial owner
Hk Zhixin Investment Co., Ltd.	2101 Beneficial owner
Li Dongfeng	2201 Interest of corporation controlled by you
Yan Kang	2201 Interest of corporation controlled by you
Qiu Zhe Feng	2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Li Yang Yi Xiong	2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines